Zhang, et al. reported that RAS GTPase-activating protein SH3 domain-binding protein 1 (G3BP1), an essential RAS mediator, participates in the progression of BC via activation of the epithelial-to-mesenchymal transition, and that it could be a potential therapeutic target for metastatic human BC [35]. The gene discussed is G3BP1; the disease is breast cancer.